They’re the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
The post Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs appeared first on Business News.